GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ca Inc. (CA) [hlAlert]

Rating:
Neutral CA
down 7.48 %

Ca Inc. (CA) downgraded to Neutral by Credit Suisse

Posted on: Monday,  Apr 20, 2009  8:25 AM ET by Credit Suisse

Credit Suisse rated Neutral Ca Inc. (NASDAQ: CA) on 04/20/2009. Previously Credit Suisse rated Outperform Ca Inc. (NASDAQ: CA) on 01/30/2009.,
when the stock price was $18.30. Since then, Ca Inc. has lost 7.49% as of 04/20/2009's recent price of $16.93.
If you would have followed the previous Credit Suisse's recommendation on CA, you would have lost 7.48% of your investment in 80 days.

Careside has developed and plans to sell a proprietary blood testing systemcalled the Careside system. It is designed to decentralize laboratoryoperations. The system consists of a testing instrument called the CareSideAnalyzer and disposable test cartridges. It performs blood tests in the same location as the patient, or what is commonly called point-of-care testing. The company's goal is to make decentralized testing with the Careside system the standard for routine and critical care blood testing.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/20/2009 8:25 AM Hold
None
16.93
as of 12/31/2009
1 Week   
1 Month   
3 Months   
1 YTD down  -8.63 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/30/2009 2:25 PM Buy
None
18.30 25.00
8/2/2007 9:25 AM Buy
None
25.92 33.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy